Author(s): van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B
Abstract Share this page
Abstract The number of patients with type 2 diabetes is increasing rapidly in both developed and developing countries around the world. The emerging pandemic is driven by the combined effects of population ageing, rising levels of obesity and inactivity, and greater longevity among patients with diabetes that is attributable to improved management. The vascular complications of type 2 diabetes account for the majority of the social and economic burden among patients and society more broadly. This review summarizes the burden of type 2 diabetes, impaired glucose tolerance, and their vascular complications. It is projected that by 2025 there will be 380 million people with type 2 diabetes and 418 million people with impaired glucose tolerance. Diabetes is a major global cause of premature mortality that is widely underestimated, because only a minority of persons with diabetes dies from a cause uniquely related to the condition. Approximately one half of patients with type 2 diabetes die prematurely of a cardiovascular cause and approximately 10\% die of renal failure. Global excess mortality attributable to diabetes in adults was estimated to be 3.8 million deaths.
This article was published in Eur J Cardiovasc Prev Rehabil
and referenced in Journal of Stem Cell Research & Therapy